Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $8.80 USD
Change Today -0.14 / -1.57%
Volume 3.6M
NVAX On Other Exchanges
As of 8:10 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - novavax inc (NVAX)

NameBoard RelationshipsTitleAge
Stanley C. Erck 18 RelationshipsChief Executive Officer, President, Director and Member of Finance Committee66
Barclay A. Phillips 10 RelationshipsChief Financial Officer, Principal Accounting Officer, Senior Vice President and Treasurer51
John Joseph Trizzino B.S., M.B.A.No RelationshipsSenior Vice President of Commercial Operations54
Sven Andreasson M.B.A.42 RelationshipsSenior Vice President of Corporate Development62
Louis Fries III M.D.No RelationshipsChief Medical Officer and Vice President --

Board Members - novavax inc (NVAX)

NameBoard RelationshipsPrimary CompanyAge
James F. Young Ph.D.65 RelationshipsNovavax, Inc.61
Stanley C. Erck 18 RelationshipsNovavax, Inc.66
Michael A. McManus Jr., J.D. 34 RelationshipsMisonix, Inc.71
Gary C. Evans 24 RelationshipsMagnum Hunter Resources Corp.57
Rajiv Indravadan Modi Ph.D.19 RelationshipsCadila Pharmaceuticals Limited54

Executive Committees* - novavax inc (NVAX)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeMichael A. McManus Jr., J.D. 34 Relationships3 Executives
Compensation CommitteeJames F. Young Ph.D. 65 Relationships3 Executives
Nominating CommitteeGary C. Evans 24 Relationships3 Executives
Corporate Governance CommitteeGary C. Evans 24 Relationships3 Executives
Finance CommitteeGary C. Evans 24 Relationships4 Executives
View NVAX Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $8.80 USD -0.14

NVAX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dynavax Technologies Corp $21.32 USD -0.24
Inovio Pharmaceuticals Inc $7.35 USD -0.21
Peregrine Pharmaceuticals Inc $1.63 USD +0.06
Progenics Pharmaceuticals Inc $6.95 USD +0.13
ZIOPHARM Oncology Inc $13.38 USD -0.43
View Industry Companies

Industry Analysis


Industry Average

Valuation NVAX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 69.6x
Price/Book 9.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 64.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at